Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.64 -0.16 (-0.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Total Current Liabilities (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) reported Total Current Liabilities of $502.91 million for Q2 2026, down 45.3% from $919.95 million a year earlier but up 0.8% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Sarepta Therapeutics posted Total Current Liabilities of $1.1 billion, up 49.7% from FY2024.

  • Total Current Liabilities has increased for 12 consecutive years, with a five-year compound annual growth rate of 21.4% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $731.68 million in FY2024 (+11.9%), $653.66 million in FY2023 (+5.5%), $619.6 million in FY2022 (+36.9%) and $452.73 million in FY2021 (+8.8%).
  • Five-year quarterly Total Current Liabilities spans a low of $373.44 million in Q3 2021 and a high of $1.1 billion in Q4 2025.
  • Year over year, Total Current Liabilities gained in five of the last eight quarters, with growth averaging 14.8%.
  • The high point for year-over-year Total Current Liabilities in five years was Q3 2022 (growth of 61.4%); the low point was Q2 2026 (a decline of 45.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $499.16 million (Q1 2026), $1.1 billion (Q4 2025) and $921.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Sarepta Therapeutics 1.99 Bn -1.25 Bn 251.87 Mn 502.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 502.91 Mn
Mar 31, 2026 499.16 Mn
Dec 31, 2025 1.10 Bn
Sep 30, 2025 921.43 Mn
Jun 30, 2025 919.95 Mn
Mar 31, 2025 605.59 Mn
Dec 31, 2024 731.68 Mn
Sep 30, 2024 699.49 Mn
Jun 30, 2024 688.49 Mn
Mar 31, 2024 608.71 Mn
Dec 31, 2023 653.66 Mn
Sep 30, 2023 450.74 Mn
Jun 30, 2023 498.65 Mn
Mar 31, 2023 536.88 Mn
Dec 31, 2022 619.60 Mn
Sep 30, 2022 602.92 Mn
Jun 30, 2022 545.57 Mn
Mar 31, 2022 454.96 Mn
Dec 31, 2021 452.73 Mn
Sep 30, 2021 373.44 Mn
API Access

Sarepta Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SRPT&period=max&api_key=YOUR_API_KEY